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Background: Metabolic syndrome (MetS) is an important health problem which puts individuals at risk for
cardiovascular diseases and type 2 diabetes as well as obesity-related cancers such as colon and renal cell in men,
and endometrial and oesophageal in women.
Objective: This study was aimed at examining how obesity indicators and related determinants influence
metabolic syndrome, and how the factors can be used to predict the syndrome and its cut-offs in postmenopausal
Ghanaian women.
Methods: Two hundred and fifty (250) Ghanaian subjects were involved in the study with one hundred and forty-
three (143) being premenopausal women and one hundred and seven (107) postmenopausal women. The
influence of traditional metabolic risk factors including high blood pressure, dyslipidemia and glucose intolerance
on obesity and atherogenic indices i.e. body mass index (BMI), waist circumference (WC), waist-to-hip ratio (WHR),
Waist-to-thigh ratio (WTR), waist-to-height ratio (WHtR), high density lipoprotein cholesterol to total cholesterol ratio
(HDL-C/TC), high density lipoprotein cholesterol to low density lipoprotein ratio (HDL-C/LDL-C) and triglyceride to
high density lipoprotein cholesterol ratio (TG/HDL-C) were identified according to the Harmonization (H_MS)
criterion.
Results: The predominant anthropometric marker that significantly influence metabolic risk factors among the pre-
and postmenopausal women was waist-to-hip ratio (premenopausal: p- 0.004, 0.026 and 0.002 for systolic blood
pressure (SBP), fasting blood glucose (FBG) and HDL-C; postmenopausal: p-0.012, 0.048, 0.007 and 0.0061 for
diastolic blood pressure (DBP), FBG, triglyceride (TG) and high density lipoprotein cholesterol (HDL-C) respectively).
Using the receiver operating characteristic (ROC) analysis, the area under the curve for WC, WHR, TG/HDL-C and
HDL-C/TC among postmenopausal women were estimated at 0.6, 0.6, 0.8 and 0.8 respectively. The appropriate cut-
off values for WC, WHR, TG/HDL-C and HDL-C/TC that predicted the presence of metabolic syndrome were
80.5 cm, 0.84, 0.61 and 0.34 respectively.
Conclusion: The presence of metabolic syndrome among Ghanaian postmenopausal women can be predicted
using WC, WHR, TG/HDL-C and HDL-C/TC.
Keywords: Metabolic syndrome, Abdominal adiposity, Insulin resistance, Postmenopausal and premenopausal
women* Correspondence: fareedarthur@yahoo.com
1Department of Biochemistry and Biotechnology, College of Science, Kwame
Nkrumah University of Science and Technology, Kumasi, Ghana
Full list of author information is available at the end of the article
© 2012 Arthur et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Arthur et al. Lipids in Health and Disease 2012, 11:101 Page 2 of 13
http://www.lipidworld.com/content/11/1/101Introduction
The increase in obesity, particularly abdominal adiposity,
is closely associated with premature atherosclerosis and
many metabolic modifications including insulin resist-
ance, dyslipidemia hypertension and diabetes [1-3].
Obesity is the most common disorder associated with
women in their menopausal stage and occurs in approxi-
mately 65% of all women [4]. The development of cen-
tral obesity, insulin resistance as well as the worsening
of glucose and lipid metabolism has been associated with
menopause which results in an increased risk for
cardiovascular disease [5,6]. According to Arad et al..,
[7] central obesity contribute to the development of
insulin resistance as well as atherosclerosis in women.
Body mass index (BMI) is commonly used in public
health studies as indicator of weight status but it
does not consider the accumulation of abdominal vis-
ceral fats [8]. Waist circumference (WC), waist-hip ratio
(WHR), waist-to-thigh ratio (WTR) and waist-height
ratio (WHtR) are anthropometric measures used to
diagnose abdominal obesity, while high triglyceride
(TG) and low high density lipoprotein-cholesterol
(HDL-C) are used to define dyslipidemia. These two
markers are negatively correlated and are risk factors for
atherosclerotic cardiovascular disease and stroke [9].
Since many women with the syndrome have low
HDL-C, they often have low HDL-cholesterol/total
cholesterol (HDL-C/TC), HDL-cholesterol/low density
lipoprotein-cholesterol (HDL-C/LDL-C) and high trigly-
cerides/HDL-cholesterol ratios [10]. These ratios had
been shown to be significant predictors of atheroscler-
osis, both in Caucasians and Nigerian women [11]. The
relationship between obesity indicators such as BMI,
WC, WHR, WTR and WHtR, and traditional markers
of metabolic syndrome such as fasting glucose, triglycer-
ide, blood pressure and HDL cholesterol has not been
fully established in Ghanaian population. Moreover, the
association between obesity markers and atherogenic in-
dices such as TG/HDL-C and HDL-C/TC as well as
their ability to predict metabolic syndrome among
Ghanaian postmenopausal women has also not been
reported. This study was therefore aimed at examining
how obesity indicators and related factors affect meta-
bolic syndrome, and also to ascertain how obesity and
atherogenic indices can be used to predict the syndrome
and its cut-offs in Ghanaian postmenopausal women.
Subjects, materials and methods
Subjects
This cross-sectional study was carried out between May
and July, 2011 at the outpatient departments of Suntreso
and Seventh Day Adventist (SDA) Government Hospitals,
Ghana. Two hundred and fifty patients were randomly
recruited, of which one hundred and forty-three (143)were premenopausal women and one hundred and seven
(107) postmenopausal. The study participants were
recruited from a population of young and older women
aged 20–78 years. Women who were still menstruating ir-
respective of the regularities of their menses were consid-
ered as premenopausal women while postmenopausal
women were women who had ceased menstruation for at
least one year. The participation of the women was volun-
tary. Informed consent was obtained from each of them
after thorough explanation of the study in a language they
understand. This study was approved (CHRPE/02/11) by
the Committee on Human Research Publications and Eth-
ics, School of Medical Sciences; Kwame Nkrumah Univer-
sity of Science and Technology and Komfo Anokye
Teaching Hospital, Ghana
Sample size consideration
The 250 participants were used after the estimation of
minimum sample sizes for both pre (98) and postmeno-
pausal women (88) to achieve 80% power based on the
method suggested by [12,13]. The parameters used were:
prevalence of metabolic syndrome among pre- and post-
menopausal women 24% and 44.4% respectively [14];
24%, confidence interval of 95%, relative sample size of
0.9, probability of type II error, 20% and probability of
type I error 5%.
Inclusion and exclusion criteria
The eligible volunteers were women with no signs of
pregnancy, hypertension, type 2 diabetes, cancer, poly-
cystic ovary syndrome, hepatitis B and hormonal contra-
ceptive users. The exclusion criterion was any of the
following: clinically-confirmed pregnancy, known dia-
betics, hypertension, other heart diseases, polycystic
ovary syndrome and cancer.
Laboratory procedures
Venous blood samples were collected after overnight fast
(12–16 hours) between 7 am and 10 am. About 5 ml of
venous blood was collected; 4 ml dispensed into vacutai-
nerW plain tubes and 1 ml into fluoride oxalate tubes.
After centrifugation at 1000 rpm for 10 minutes, the
serum and plasma were stored at −80°C until assayed.
Parameters determined included: FBG, TC, TG and
HDL-C according to reagents manufacturer’s specifica-
tion (Fortress Diagnostics Limited, Antrim, United
Kingdom). Serum low density lipoprotein cholesterol
and very low density lipoprotein-cholesterol (VLDL-C)
were calculated using the Frederickson-Friedwald’s for-
mula [15]. Fasting blood glucose and total cholesterol
determination were according to the method described
by Trinder [16]. Triglycerides determination employed a
modified Trinder method. HDL-C was measured after
precipitation with phosphotungstic acid in the presence
Table 1 Baseline characteristics of study population
Characteristics Total Postmenopausal Premenopausal P value
Number of Subjects 250 107 143
Age (years) 44.23 ± 0.90 57.25 ± 0.80 34.48 ± 0.74 <0.0001
Waist Circ. (cm) 92.41 ± 0.72 95.93 ± 0.94 89.85 ± 1.01 <0.0001
Thigh Circ. (cm) 55.64 ± 0.41 56.43 ± 0.80 55.34 ± 0.53 0.2380
BMI (kg/m²) 26.64 ± 0.32 27.25 ± 0.57 26.41 ± 0.44 0.2350
WHR 0.88 ± 0.00 0.91 ± 0.01 0.87 ± 0.01 <0.0001
WTR 1.67 ± 0.01 1.72 ± 0.01 1.62 ± 0.01 <0.0001
HTR 1.88 ± 0.01 1.95 ± 0.06 1.87 ± 0.01 0.1836
WHtR 0.58 ± 0.00 0.60 ± 0.01 0.56 ± 0.01 <0.0001
SBP (mmHg) 132.5 ± 1.19 140.1 ± 1.81 126.4 ± 1.44 <0.0001
DBP (mmHg) 86.3 ± 0.73 89.59 ± 1.12 83.62 ± 0.93 <0.0001
PP (mmHg) 46.2 ± 0.76 50.76 ± 1.12 42.73 ± 0.93 <0.0001
FBG (mmol/l) 5.19 ± 0.08 5.60 ± 0.15 4.9 ± 0.07 <0.0001
TG (mmol/l) 1.20 ± 0.03 1.31 ± 0.06 1.12 ± 0.04 0.0060
TC (mmol/l) 4.40 ± 0.05 4.41 ± 0.08 4.40 ± 0.07 0.8500
HDL-C (mmol/l) 1.34 ± 0.02 1.31 ± 0.03 1.37 ± 0.02 0.0670
LDL-C (mmol/l) 2.51 ± 0.05 2.50 ± 0.08 2.52 ± 0.06 0.9130
VLDL-C (mmol/l) 0.42 ± 0.01 0.46 ± 0.02 0.40 ± 0.01 0.0060
HDL-C/TC 0.31 ± 0.00 0.30 ± 0.01 0.32 ± 0.01 0.0700
HDL-C/LDL-C 0.59 ± 0.02 0.84 ± 0.13 0.64 ± 0.04 0.0970
TG/HDL-C 0.97 ± 0.04 1.11 ± 0.08 0.86 ±0.04 0.0040
Continuous data were presented as mean ± standard error of mean (SEM). VLDL-C: Very Low Density Lipoprotein-Cholesterol, LDL-C: Low Density Lipoprotein-
Cholesterol, HDL-C: High Density Lipoprotein, TC: Total Cholesterol, TG: Triglycerides, FBG: Fasting Blood Glucose, WHR: Waist-to-Hip Ratio, BMI: Body Mass Index,
WC: Waist Circumference, WTR: Waist-to-Thigh Ratio, WHtR: Waist-to-Height Ratio, HTR: hip-to-thigh circumference, SBP: Systolic Blood Pressure, DBP: Diastolic
Blood Pressure, PP: Pulse Pressure, Circ: Circumference.
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HDL-C/TC and LDL-C/HDL-C and HDL-C/VLDL-C
were calculated using Microsoft Excel.
Anthropometric variables
Anthropometric measurements included height to the
nearest centimetre without shoes and weight to the
nearest 0.1 kg in light clothing. Subjects were weighed
on a bathroom scale (BR9012; Zhongshan Camry Elec-
tronic Co. Ltd, Guangdong, China) and their height
measured with a wall-mounted ruler. BMI was calcu-
lated by dividing weight (kg) by height squared (m²).
Waist circumference was measured at the midpoint be-
tween the last rib and the iliac crest with the participants
standing and wearing light cloths with a Gulick II
spring-loaded measuring tape (Gay Mills, WI). The hip
circumference was measured at the widest level over the
greater trochanters and the WHR calculated by dividing
the waist circumference (cm) by the hip circumference
(cm). Thigh circumference on the other hand was mea-
sured on the left leg below the gluteal fold and waist to
thigh ratio calculated by dividing waist circumference
(cm) by the thigh circumference (cm).Blood pressure
Blood pressure was measured by a trained nurse with
participants in sitting position and having rested for at
least 10 minutes using sphygmomanometer and appro-
priate cuff sizes. Three separate readings were taken per
subject, after two minutes intervals and the lowest read-
ings recorded. Systolic blood pressure (SBP) and dia-
stolic blood pressure (DBP) were taken at the 1st and 5th
Korotkoff sounds respectively. Pulse pressure was calcu-
lated using SBP-DBP.
Definition of metabolic syndrome
Harmonization (H_MS)
Metabolic risk factors were identified based on the defin-
ition released by an expert group from the International
Diabetes Federation (IDF), National Heart, Lung, Blood
Institute (NHLBI), World Health Federation and other
international associations which proposed a harmonized
definition (H_MS) [17,18] that uses uniform cut-off points
for all the risk factors and recommended that individuals
with metabolic syndrome should have any three of the fol-
lowing five components: (1) waist measurement >80 cm
for women; (2) TG levels of 1.7 mmol/ L or greater, (3)
Table 2 BMI, WC, WTR, WHR and WHtR values according to the various cut-offs of different metabolic risk factors in
pre- and postmenopausal Ghanaian women using H_MS Criterion
Postmenopausal Premenopausal
Parameters BMI WC WHR WTR WHtR BMI WC WHR WTR WHtR
Systolic Blood Pressure
<130 mmHg 24.19 ± 0.80 92.50 ± 1.80 0.92 ± 0.01 1.70 ± 0.02 0.58 ± 0.01 25.37 ± 0.50 87.10 ± 1.10 0.85 ± 0.01 1.60 ± 0.01 0.54 ± 0.01
≥130 mmHg 27.65 ± 0.50 96.80 ± 1.10 0.91 ± 0.01 1.73 ± 0.02 0.61 ± 0.01 28.11 ± 0.80 94.39 ± 1.90 0.89 ± 0.01 1.67 ± 0.02 0.59 ± 0.01
p value 0.0010 0.0530 0.5830 0.2540 0.1360 0.0030 0.0004 0.0004 0.0030 0.0010
Diastolic Blood Pressure
<85 mmHg 24.59 ± 0.70 94.00 ± 1.60 0.93 ± 0.01 1.70 ± 0.02 0.59 ± 0.01 25.10 ± 0.50 86.96 ± 1.10 0.86 ± 0.01 1.62 ± 0.01 0.54 ± 0.01
≥85 mmHg 27.86 ± 0.60 96.61 ± 1.10 0.91 ± 0.01 1.73 ± 0.02 0.60 ± 0.01 28.34 ± 0.80 93.97 ± 1.80 0.87 ± 0.01 1.65 ± 0.02 0.59 ± 0.01
p value 0.0010 0.1990 0.0120 0.3430 0.7580 0.00020 0.0010 0.1180 0.2040 0.0010
Fasting Blood Glucose
<5.6 mmol/l 26.64 ± 0.60 93.91 ± 1.20 0.91 ± 0.01 1.76 ± 0.02 0.58 ± 0.01 26.81 ± 0.50 90.04 ± 1.10 0.86 ± 0.01 1.62 ± 0.01 0.56 ± 0.01
≥5.6 mmol/l 27.13 ± 0.70 99.18 ± 1.50 0.93 ± 0.01 1.66 ± 0.01 0.63 ± 0.01 24.98 ± 0.90 88.87 ± 2.30 0.89 ± 0.01 1.63 ± 0.02 0.55 ± 0.02
p value 0.6060 0.0060 0.0480 <0.0001 0.0003 0.1400 0.6720 0.0260 0.7090 0.7290
Triglyceride
<1.7 mmol/l 26.62 ± 0.50 94.76 ± 1.00 0.91 ± 0.01 1.73 ± 0.01 0.59 ± 0.01 26.30 ± 0.50 89.37 ± 1.04 0.87 ± 0.01 1.62 ± 0.01 0.56 ± 0.01
≥1.7 mmol/l 28.32 ± 1.00 102.4 ± 1.50 0.95 ± 0.01 1.65 ± 0.02 0.64 ± 0.01 28.21 ± 1.70 97.00 ± 3.60 0.89 ± 0.02 1.64 ± 0.01 0.60 ± 0.03
p value 0.1930 0.0040 0.0070 0.0320 0.0070 0.2970 0.0670 0.1540 0.7600 0.0890
HDL-C
<1.30 mmol/l 26.41 ± 0.60 96.76 ± 1.40 0.93 ± 0.01 1.69 ± 0.02 0.61 ± 0.01 26.09 ± 0.80 90.97 ± 2.00 0.89 ± 0.01 1.62 ± 0.01 0.57 ± 0.01
≥1.30 mmol/l 26.98 ± 0.60 95.34 ± 1.20 0.90 ± 0.01 1.74 ± 0.02 0.59 ± 0.01 26.56 ± 0.50 89.49 ± 1.20 0.86 ± 0.01 1.62 ± 0.01 0.56 ± 0.01
p value 0.5530 0.4710 0.00610 0.0690 0.3450 0.6510 0.5310 0.0020 0.9820 0.4920
Continuous data were presented as mean ± standard error of mean (SEM). HDL-C: High Density Lipoprotein, WHR: Waist-to-Hip Ratio, BMI: Body Mass Index, WC:
Waist Circumference, WTR: Waist-to-Thigh Ratio, WHtR: Waist-to-Height Ratio.
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130/85 mm Hg or greater and (5) FBG of 5.6 mmol/L or
greater. The pre- and postmenopausal women were cate-
gorized using this criterion.
Statistical analyses
Normality of all variables was tested and found to be
normal before the statistical analyses using the D’
Agostino-Pearson procedure. All clinical and biochem-
ical data of study subjects were expressed as means ±
SEM. The differences between groups were examined
by unpaired t-test. Areas under the curve (AUC) for the
atherogenic and obesity markers were measured through
ROC curve analysis for the diagnosis of metabolic syn-
drome amongst pre- and postmenopausal women. The
diagnostic performance characteristics in terms of sensi-
tivity and specificity were calculated at different cut-offs
for those markers which showed higher AUC. The sig-
nificance of the difference between the area under the
curves derived from pre and postmenopausal samples
were calculated using the formula suggested by [19]. To
compare differences between premenopausal and post-
menopausal women with and without the syndrome,
one way analysis of variance (ANOVA) followed byTukey’s multiple test to compare all pairs of columns
were performed. All p values were two-sided and the
level of significance was 0.05 after Bonferroni correction
[20]. GraphPad Prism version 5.00 (GraphPad software,
San Diego California, USA; www.graphpad.com) and
Statistical Package for the Social Sciences (SPSS) version
16.00 for windows (SPSS Inc, Chicago, USA; www.spss.
com) were used for statistical analysis.
Results
Baseline characteristics of the study population
Table 1 shows the baseline characteristics of the study
population. The mean age of postmenopausal (57.25± 0.8)
was significantly higher (p< 0.0001) than the mean age of
the premenopausal (34.48± 0.7). Postmenopausal women
had significantly (p < 0.0001) larger WC, higher mean
WHR, WTR, WHtR, SBP, DBP and PP than their preme-
nopausal counterpart except BMI (p= 0.4152, Table 1).
Compared to premenopausal women, postmenopausal
counterparts had significantly (p < 0.05) raised levels of
TG, VLDL-C, and FBG, though these levels were within
normal range. The mean TG/HDL-C ratio was higher
(p= 0.0040) among the postmenopausal group (Table 1).
However, postmenopausal women had reduced HDL-C as
Table 3 TG/HDL-C, HDL-C/TC and HDL-C/LDL-C values according to the various cut-offs of different metabolic risk
factors in pre- and postmenopausal Ghanaian women using H_MS Criterion
Postmenopausal Premenopausal
Parameters TG/HDL-C HDL-C/TC HDL-C/LDL-C TG/HDL-C HDL-C/TC HDL-C/LDL-C
Systolic Blood Pressure
<130 mmHg 1.06 ± 0.11 0.33 ± 0.02 1.17 ± 0.48 0.71 ± 0.02 0.31 ± 0.01 0.57 ± 0.03
≥130 mmHg 1.11 ± 0.10 0.31 ± 0.01 0.74 ± 0.09 1.13 ± 0.09 0.34 ± 0.01 0.76 ± 0.08
p value 0.8290 0.5800 0.1490 <0.0001 0.0980 0.0140
Diastolic Blood Pressure
<85 mmHg 1.12 ± 0.10 0.33 ± 0.02 1.14 ± 0.37 0.71 ± 0.02 0.32 ± 0.01 0.58 ± 0.03
≥85 mmHg 1.09 ± 0.11 0.31 ± 0.01 0.70 ± 0.09 1.09 ± 0.08 0.33 ± 0.01 0.77 ± 0.08
p value 0.8640 0.2410 0.1070 <0.0001 0.2290 0.0210
Fasting Blood Glucose
<5.6 mmol/l 0.72 ± 0.02 0.33 ± 0.01 0.64 ± 0.05 0.75 ± 0.02 0.32 ± 0.01 0.63 ± 0.04
≥5.6 mmol/l 1.76 ± 0.18 0.29 ± 0.02 1.16 ± 0.33 1.47 ± 0.18 0.33 ± 0.02 0.66 ± 0.09
p value <0.0001 0.0880 0.0470 <0.0001 0.8380 0.7730
Triglyceride
<1.7 mmol/l 0.84 ± 0.03 0.32 ± 0.01 0.66 ± 0.05 0.77 ± 0.02 0.33 ± 0.01 0.65 ± 0.04
≥1.7 mmol/l 2.69 ± 0.32 0.28 ± 0.03 1.87 ± 0.81 2.26 ± 0.27 0.28 ± 0.03 0.56 ± 0.12
p value <0.0001 0.1850 0.0010 <0.0001 0.1040 0.5550
HDL-C
<1.30 mmol/l 1.74 ± 0.20 0.24 ± 0.01 0.65 ± 0.17 1.26 ± 0.14 0.25 ± 0.01 0.44 ± 0.04
≥1.30 mmol/l 0.77 ± 0.03 0.36 ± 0.01 0.93 ± 0.17 0.74 ± 0.02 0.35 ± 0.01 0.72 ± 0.05
p value <0.00010 <0.00010 0.2990 <0.00010 <0.00010 0.0010
Continuous data were presented as mean ± standard error of mean (SEM). LDL-C: Low Density Lipoprotein-Cholesterol, HDL-C: High Density Lipoprotein, TC: Total
Cholesterol, TG: Triglycerides.
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not statistically significant (Table 1).Influence of obesity markers on metabolic risk factors
Table 2 shows the influence of BMI, WC, WTR, WHR,
WHtR on the cut-offs of BP, FBG, TG, and HDL-C in
postmenopausal and premenopausal women separately
using H_MS criterion. Postmenopausal women with
elevated BMI and WHR (p = 0.0010 and 0.0120 respect-
ively) had raised SBP (>130 mmHg), whereas premeno-
pausal women with high BMI, WC, WHR, WTR and
WHtR (p = 0.0030, 0.0004, 0.0004, 0.0030 and 0.0010 re-
spectively) had raised SBP (>130 mmHg) respectively
(Table 2). Postmenopausal women with high WC, WHR,
and WHtR had significantly (p = 0.0060, 0.0480, <0.0001
and 0.0003 respectively) raised FBG levels (≥5.6 mmol/l)
while high WTR (p < 0.0001) was rather linked to low
FBG (less than 5.6 mmol/l). On the other hand, among
premenopausal subjects, only elevated WHR (p = 0.0260)
was associated with raised fasting blood glucose
(Table 2). Similarly, elevated WC, WHR, less WTR and
WHtR (p = 0.0040, 0.0070, 0.0320 and 0.0070 respect-
ively) were linked to raise triglyceride (≥1.7 mmol/l)among postmenopausal women. Finally, only WHR
(p = 0.0060 and 0.0020 respectively) had influence on
reduced HDL-C (<1.30 mmol/l) among postmenopausal
and premenopausal populations (Table 2).Influence of atherogenic indices on metabolic risk factors
The influence of atherogenic indices such as TG/HDL-C,
HDL-C/TC and HDL-C/LDLC and traditional metabolic
risk factors is shown in Table 3. Premenopausal women
(p< 0.0001 and 0.0140 respectively) with raised blood
pressure (>130 mmHg) had increased TG/HDL-C and
HDL-C/LDL-C ratios (Table 3). Among postmenopausal
women, raised fasting blood glucose and triglyceride levels
were common with higher TG/HDL-C and HDL-C/LDL-
C ratios (p< 0.0001, 0.0470, <0.0001 and 0.0010 respect-
ively) but only with TG/HDL-C ratio (p < 0.0001 for both)
in premenopausal groups (Table 3). Finally, reduced levels
of HDL-C were noticeable in elevated TG/HDL-C ratio
(p< 0.0001) and reduced HDL-C/TC ratio (p< 0.0001) in
postmenopausal group whereas it was apparent in higher
TG/HDL-C ratio (p< 0.0001) but in lower HDL-C/TC
ratios (p< 0.0001 and 0.0010 respectively) among preme-
nopausal subjects (Table 3).
Table 4 Comparison of Metabolic Indicators among Pre and Postmenopausal Women with and without Metabolic
Syndrome
Parameters POWtM POWM PRWM PRWtM p value
(n = 60) (n = 47) (n = 29) (n = 114)
H_MS
Age (yrs) 57.53 ± 1.13{{{*** 56.89 ± 1.13###}}} 38.38 ± 1.64} 33.49 ± 0.81 <0.0001
SBP (mmHg) 142.0 ± 2.56*** 138.9 ± 2.26}}} 134.0 ± 4.02} 124.4 ± 1.44 <0.0001
DBP (mmHg) 91.33 ± 1.64 88.00 ± 1.28### 85.48 ± 2.48 83.19 ± 0.98 <0.0001
FBG (mmol/l) 4.78 ± 0.11{{{ 6.59 ± 0.23†††}}} 6.03 ± 0.21}}} 4.61 ± 0.05 <0.0001
TG (mmol/l) 1.10 ± 0.02{ 1.57 ± 0.13†††}}} 1.46 ± 0.15}} 1.05 ± 0.02 <0.0001
HDL-C (mmol/l) 1.49 ± 0.02†††{{{ 1.08 ± 0.04 1.12 ± 0.04 1.43 ± 0.02}}}}}} <0.0001
HDL-C:TC ratio 0.33 ± 0.01††† 0.27 ± 0.01 0.29 ± 0.02 0.32 ± 0.01}}} <0.0001
TG:HDL-C ratio 0.74 ± 0.01 1.58 ± 0.16†††}}} 1.34 ± 0.15{{{}}} 0.74 ± 0.02 <0.0001
HDL-C:LDL-C ratio 0.59 ± 0.01 0.57 ± 0.05 0.65 ± 0.09 0.58 ± 0.01 0.5519
HDL-C:VLDL-C ratio 3.89 ± 0.08†††{{{ 2.59 ± 0.22 2.82 ± 0.29 4.03 ± 0.09}}}}}} <0.0001
BMI (kg/m²) 26.52 ± 0.64 27.44 ± 0.64 26.40 ± 0.77 26.48 ± 0.52 0.7041
WHR 0.90 ± 0.01*** 0.93 ± 0.01##}}} 0.89 ± 0.01 0.86 ± 0.01 <0.0001
WTR 1.75 ± 0.02{{{*** 1.68 ± 0.02 1.63 ± 0.02 1.62 ± 0.01 <0.0001
WHtR 0.59 ± 0.01* 0.61 ± 0.01##}}} 0.56 ± 0.01 0.55 ± 0.01 <0.0001
Data were presented as mean ± standard error of mean (SEM). POWtM: postmenopausal women without the syndrome, POWM: postmenopausal women with the
syndrome, PRWM: premenopausal women with the syndrome, PRWtM: premenopausal women without the syndrome, LDL-C: Low Density Lipoprotein-Cholesterol,
HDL-C: High Density Lipoprotein, TC: Total Cholesterol, TG: Triglycerides, FBG: Fasting Blood Glucose, WHR: Waist-to-Hip Ratio, BMI: Body Mass Index, WTR: Waist-to-
Thigh Ratio, WHtR: Waist-to-Height Ratio, SBP: Systolic Blood Pressure, DBP: Diastolic Blood Pressure, WHR: Waist-to-Hip Ratio, BMI: Body Mass Index, WC: Waist
Circumference, THC: Thigh Circumference, WTR: Waist-to-Thigh Ratio, WHtR: Waist-to-Height Ratio, HTR: hip-to-thigh circumference. *Each comparison was
performed between pre and postmenopausal women with and without metabolic syndrome. .*p < 0.05, **p < 0.001, ***p < 0.0001, comparison of POWtM with
PRWtM; †p< 0.05, †† p< 0.001, ††† p< 0.0001, comparison of POWtM with POWM; { p< 0.05, {{ p< 0.001, {{{ p < 0.0001, comparison of POWtM with PRWM; }
p< 0.05, }} p< 0.001, }}} p< 0.0001, comparison of PRWM with PRWtM; } p< 0.05, }} p< 0.001, }}} p< 0.0001, comparison of POWM with PRWtM; # p < 0.05, ##
p < 0.001, ### p < 0.0001, comparison of POWM with PRWM.
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postmenopausal women with and without metabolic
syndrome
Table 4 presents the comparison of metabolic indicators
among pre- and postmenopausal women with and with-
out (PRWM, PRWtM, POWM and POWtM) the syn-
drome. Systolic blood pressure was significantly higherTable 5 Area under Curves of BMI, WC, WTR, WHR, TG/HDL-C
BMI WC WTR
POSTMENOPAUSAL
Blood Pressure 0.7(0.6-0.9)* 0.6(0.5-0.8) 0.7(0.5-0.8)*
Glucose 0.5(0.4-0.6) 0.7(0.6-0.8)* 0.3(0.2-0.4)
HDL-C 0.5(0.4-0.6) 0.6(0.5-0.7) 0.4(0.3-0.5)
Metabolic Syndrome 0.6(0.5-0.7) 0.6(0.5-0.7)* 0.4(0.3-0.5)
PREMENOPAUSAL
Blood Pressure 0.6(0.5-0.7)* 0.6(0.5-0.7)* 0.6(0.5-0.7)
Glucose 0.4(0.3-0.5) 0.5(0.4-0.6) 0.6(0.5-0.7)
HDL-C 0.5(0.4-0.6) 0.5(0.4-0.6) 0.6(0.5-0.7)
Metabolic Syndrome 0.5(0.4-0.6) 0.5(0.4-0.6) 0.6(0.5-0.7)
All values were AUC (95%CI), AUC, area under curves; CI, confidence interval, *P < 0
mean ± standard error of mean (SEM). HDL-C: High Density Lipoprotein, WHR: Waist
Height Ratio, WHR: Waist-to-Hip Ratio, BMI: Body Mass Index, WC: Waist Circumferen
was performed between pre and postmenopausal women with and without metabamong both postmenopausal group and PRWM than
PRWtM. Similarly, fasting blood glucose levels of
POWM and PRWM were significantly higher than
POWtM and PRWtM (Table 4). Postmenopausal women
with the syndrome had significantly raised triglyceride
levels as compare to all the other groups. However,
HDL-C levels were significantly reduced among POWM, HDL-C/TC and WHtR for Metabolic Syndrome
WHR WHtR TG/HDL-C HDL-C/TC
0.4(0.3-0.6) 0.7(0.5-0.8)* 0.6(0.4-0.7) 0.5(0.4-0.7)
0.6(0.5-0.7)* 0.6(0.5-0.7)* 0.8(0.7-0.9)*** 0.7(0.6-0.8)*
0.7(0.6-0.8)* 0.5(0.4-0.6) 0.8(0.7-0.9)*** 0.8(0.7-0.9)***
0.6(0.5-0.7)* 0.6(0.5-0.7) 0.8(0.7-0.9)*** 0.8(0.7-0.9)***
0.6(0.5-0.7)* 0.6(0.5-0.7)* 0.5(0.4-0.6) 0.5(0.4-0.6)
0.7(0.6-0.8)* 0.5(0.4-0.6) 0.8(0.7-0.9)*** 0.6(0.5-0.8)*
0.7(0.6-0.8)* 0.5(0.4-0.6) 0.7(0.6-0.8)* 0.7(0.6-0.8)***
0.6(0.5-0.7)* 0.5(0.4-0.6) 0.8(0.7-0.9)*** 0.6(0.5-0.8)*
.05. **P < 0.001 **P < 0.0001 Continuous data were presented as
-to-Hip Ratio, BMI: Body Mass Index, WTR: Waist-to-Thigh Ratio, WHtR: Waist-to-
ce, WTR: Waist-to-Thigh Ratio, WHtR: Waist-to-Height Ratio. Each comparison
olic syndrome.
Figure 1 The ROC (receiver operating characteristic) curves A, B, C, and D for BMI, WC, WHtR, WTR, WHR, and TG/HDL-C as well as
HDL-C/TC and TG/HDL-C to detect high blood pressure in postmenopausal and premenopausal Ghanaian Women respectively.
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http://www.lipidworld.com/content/11/1/101and PRWM than their counterparts without the syn-
drome. The ratios of HDL-C/VLDL-C and HDL-C/TC
were significantly lower in Ghanaian women with the
syndrome than those without the syndrome. Finally, the
values of WHR, WTR and WHtR were significantly
higher in postmenopausal groups than those in preme-
nopausal groups (Table 4).
Prediction of metabolic syndrome among pre- and
postmenopausal women using atherogenic and obesity
indices
The area under curves (AUCs) of those lipid and
obesity-based markers which showed significant predic-
tion of high blood pressure, fasting blood glucose, low
HDL-C and metabolic syndrome is shown in Tables 5
and Figures 1, 2, 3 and 4.In postmenopausal subjects with the cut-off value of
23.1 kg/m² (for BMI), 1.58 (for WTR), 0.53 (for
WHtR), the sensitivity and specificity were 81.8% and
57.9%, 93.2% and 84.2%, 88.6% and 73.7%, respectively,
which were found to detect high blood pressure
(Table 6). The cutoff values for detecting fasting blood
glucose were 81.5 cm (for WC), 0.84 (for WHR), 0.51
(for WHtR), 0.60 (for TG/HDL-C), 0.34 (for HDL-C/
TC) and the corresponding sensitivity and specificity
were 94.9% and 89.7%, 97.4% and 97.1%, 97.4% and
89.7%, 97.4% and 89.7%, 79.5% and 67.6% respectively
in postmenopausal women (Table 7). The cut-off
values to detect low HDL-C were 0.85 for WHR (sen-
sitivity and specificity were 97.4% and 89.9%), 0.63 for
TG/HDL-C (sensitivity and specificity were 89.5% and
87%), 0.32 for HDL-C/TC (sensitivity and specificity
Figure 2 The ROC (receiver operating characteristic) curves A, B, C, and D for BMI, WC, WHtR, WTR, WHR, and TG/HDL-C as well as
HDL-C/TC and TG/HDL-C to detect high glucose level in postmenopausal and premenopausal Ghanaian Women respectively.
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http://www.lipidworld.com/content/11/1/101were 81.6% and 36.2%) (Table 8). The cut-off values to
detect metabolic syndrome in postmenopausal women
were 80.5 cm (for WC), 0.84 (for WHR), 0.61 (for
TG/HDL-C), and the corresponding sensitivity and
specificity were 95.7% and 91.7%, 97.9% and 93.3%,
87.2% and 80%, 91.5% and 88.3%, respectively
(Table 9).
Based upon the studied data, the various cut-offs with
their sensitivities and specificities for premenopausal
women are presented in Tables 6, 7, 8 and 9 whereas
Tables 10 and 11 show the comparison of area under
ROC curves between pre- and postmenopausal women.
Discussion
Obesity and insulin resistance have been suggested to
play important pathophysiological role in the etiology ofmetabolic syndrome as well as diseases connected to it
[21,22]. The accumulation of fat in intra-abdominal
depot is more common in postmenopausal women than
their premenopausal counterparts and hence postmeno-
pausal subjects have a greater risk of developing
metabolic complications such as type 2 diabetes, hyper-
tension, atherosclerosis and coronary artery disease
(CAD) as well as obesity-related cancers [23]. Central
obesity progressively increases hepatic and adipose-
tissue insulin resistance and its resultant metabolic
abnormalities like glucose intolerance, low HDL-C, ele-
vated TG and hypertension [24,25]. Two hypotheses
have been proposed in several studies [26-28] to explain
the strong relationship between intra-abdominal fat ac-
cumulation and insulin resistance. Foremost, intra-
abdominal adiposities are more biologically active and
Figure 3 The ROC (receiver operating characteristic) curves A, B, C, and D for BMI, WC, WHtR, WTR, WHR, and TG/HDL-C as well as
HDL-C/TC and TG/HDL-C to detect low HDL-C level in postmenopausal and premenopausal Ghanaian Women respectively.
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http://www.lipidworld.com/content/11/1/101are located near portal vein which carries blood from
the intestinal area to the liver. Substances released by
intra-abdominal fat, including free fatty acids enter the
portal circulation and to the liver and subsequently in-
fluence glucose metabolism as well as blood lipids pro-
duction [29]. Secondly, visceral adipose tissue and its
resident macrophages produce more inflammatory cyto-
kines like tumor necrosis factor-alpha (TNF- α) and
interleukin-6 (IL-6) and less adiponectin [30]. The
change in levels of cytokines induces insulin resistance
by depressing the synthesis of glucose transport protein,
GLUT 4.
This present study suggests that WC, WHR, TG/
HDL-C as well as HDL-C/TC values are significant indi-
cators to identify the presence of metabolic syndrome in
Ghanaian postmenopausal women (Tables 9). The cut-
offs values of the markers to predict the syndrome in
Ghanaian postmenopausal women are 80.5 cm, 0.84,0.61 and 0.34 for WC, WHR, HDL-C/TC and TG/HDL-
C respectively. This finding partially agrees with a simi-
lar study conducted among Chinese postmenopausal
women by Ruan et al., [31] which identified cut-off for
WC to be 80.75 cm. This study also partially agrees with
the IDF and WHO recommended WC and WHR cut-off
points for European women (80 cm, 88 cm and 0.85 re-
spectively) and other Eastern Mediterranean countries
[32,33]. Similarly, WC cut-off points of 72, 82, 85, 86
and 88 cm provided the highest sensitivity for identifying
hypertension in Nigerian, Cameroonian, Jamaican, St
Lucian and Barbadians women respectively [34]. Even
though BMI and WHtR had been explored to predict
metabolic syndrome in several studies [31,35,36] , in this
present study, the ROC analyses showed that BMI and
WHtR could not be used to predict the presence of syn-
drome among Ghanaian postmenopausal women
(Table 5). In general women in Ghana are defined as
Figure 4 The ROC (receiver operating characteristic) curves A, B, C, and D for BMI, WC, WHtR, WTR, WHR, and TG/HDL-C as well as
HDL-C/TC and TG/HDL-C to detect metabolic syndrome among postmenopausal and premenopausal Ghanaian Women respectively.
Table 6 Cutoffs of the Obesity indicators to predict High
Blood Pressure in Pre- and Postmenopausal Ghanaian
Parameters Cut-off Sensitivity Specificity
POSTMENOPAUSAL
BMI (Kg/m²) 23.1 0.818 0.579
WTR 1.58 0.932 0.842
WHtR 0.53 0.886 0.737
PREMENOPAUSAL
BMI (Kg/m²) 22.9 0.817 0.681
WC (cm) 80.5 0.803 0.722
WHR 0.80 0.915 0.861
WHtR 0.50 0.817 0.778
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http://www.lipidworld.com/content/11/1/101being overweight with BMI of 25 kg/ m² according to
WHO criterion [37] but with a cut-off point of 23 kg/m²
identified in both groups, there is the possibility that
Ghanaian women develop metabolic syndrome at a
lower anthropometric indices than the western popula-
tions. The accuracy of anthropometric variables as indi-
cators of the syndrome was not high, as Swets [38] had
postulated that 0.5 >AUC< 0.7 is an indication of the
diagnostic being less accurate when ROC curves are ap-
plied in the diagnosis of conditions.
The use of TG/HDL-C and HDL-C/TC ratios to predict
the presence of the syndrome had not been studied in
Ghana. These ratios were able to predict the presence of
the syndrome in Ghanaian postmenopausal women in this
study. Since visceral adiposity is associated with hypertri-
glyceridemia, reduced HDL-C as well as insulin resistance,
there is the likelihood that TG/HDL-C and HDL-C/TC
ratios play important role in the pathogenesis of the
Table 7 Cutoffs of the Atherogenic and Obesity indicators
to predict High Glucose Level in Pre- and Postmenopausal
Ghanaian
Parameters Cut-off Sensitivity Specificity
POSTMENOPAUSAL
WC (cm) 81.5 0.949 0.897
WHR 0.84 0.974 0.971
WHtR 0.51 0.974 0.897
TG/HDL-C 0.60 0.974 0.897
HDL-C/TC 0.34 0.795 0.676
PREMENOPAUSAL
WHR 0.82 0.913 0.783
TG/HDL-C 0.65 0.957 0.708
HDL-C/TC 0.33 0.565 0.467
Table 9 Cutoffs of the Atherogenic and Obesity indicators
to predict MetS in Pre- and Postmenopausal Ghanaian
Parameters Cut-off Sensitivity Specificity
POSTMENOPAUSAL
WC 80.5 cm 0.957 0.917
WHR 0.84 0.979 0.933
TG/HDL-C 0.61 0.872 0.800
HDL-C/TC 0.34 0.915 0.883
PREMENOPAUSAL 0.81 0.966 0.833
WHR
TG/HDL-C 0.58 0.931 0.886
HDL-C/TC 0.34 0.724 0.632
Table 10 The comparison of ROC curves for blood
pressure and fasting blood glucose between
premenopausal and postmenopausal women
Variables Premenopausal Postmenopausal p value
Blood Pressure
BMI 0.621 0.733 0.1339
WC 0.608 0.627 0.8225
WTR 0.587 0.646 0.4775
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http://www.lipidworld.com/content/11/1/101syndrome and atherosclerosis. Plasma TG, TC and HDL-
C are inversely related [39]. The enzyme Cholesterol-Ester
Transfer Protein (CETP) balances the levels of TG and
HDL-C, hence responsible for the joint exchange of TG
and cholesterol ester between apoB-containing lipopro-
teins (chylomicrons, VLDL and LDL) and HDL. It has
been postulated that high CETP activity explains some of
the high TG levels and low HDL-C levels as witnessed in
women with MetS [39].
Both obesity and atherogenic markers influence trad-
itional metabolic risk factors in Ghanaian women. Liu
et al., [35] observed higher BMI, WC and WHtR values
in Chinese women with high blood pressure, fasting
blood glucose and triglyceride. Visceral abdominal fat
had been recognized to predict insulin resistance and
the presence of related metabolic abnormalities through
overexposure of liver to free fatty acids [40-44]. Body
composition changes occur in women mostly after
menopause due to decrease secretion of oestrogen [22],
resulting to age-related increases in obesity as well as
metabolic disturbances [45]. In the present study, small
WTR values were related to high FBG and TG amongTable 8 Cutoffs of the Atherogenic and Obesity indicators
to predict Low HDL-C in Pre- and Postmenopausal
Ghanaian
Parameters Cut-off Sensitivity Specificity
POSTMENOPAUSAL
WHR 0.85 0.974 0.899
TG/HDL-C 0.63 0.895 0.870
HDL-C/TC 0.32 0.816 0.362
PREMENOPAUSAL
WHR 0.80 0.973 0.858
TG/HDL-C 0.58 0.865 0.906
HDL-C/TC 0.34 0.757 0.613postmenopausal women (Table 2). This implies that
Ghanaian postmenopausal women with smaller waist
and larger thigh circumferences are at high risk of meta-
bolic syndrome. Contrary, Snijder et al, [46] identified
the association of lower risk of diabetes with larger thigh
circumference among European women. Ryan et al., [47]
also showed that African-American postmenopausal
women had 34% greater midthigh low-density lean tissue
area (a marker of intramuscular lipid content) than Cau-
casian postmenopausal women. The reason for the ob-
servation in Ghanaian postmenopausal women may be
due to physical inactivity which could result in decrease
and increase in muscle mass and visceral fat accumula-
tion respectively in their thighs. Despite paucity ofWHR 0.589 0.418 0.0617
WHTR 0.596 0.641 0.5873
TG/HDL-C 0.521 0.571 0.5691
HDL-C/TC 0.520 0.476 0.6299
Fasting Blood Glucose
BMI 0.427 0.524 0.2585
WC 0.492 0.680 0.0286
WTR 0.593 0.290 0.0003
WHR 0.669 0.629 0.6467
WHTR 0.468 0.623 0.0733
TG/HDL-C 0.796 0.824 0.7032
HDL-C/TC 0.631 0.674 0.6209
All values were area under the curve (AUC).
Table 11 The comparison of ROC curves for high density
lipoprotein cholesterol and metabolic syndrome between
premenopausal and postmenopausal women
Variables Premenopausal Postmenopausal p value
High Density Lipoprotein Cholesterol
BMI 0.499 0.474 0.7534
WC 0.523 0.569 0.5653
WTR 0.56 0.427 0.0932
WHR 0.675 0.681 0.9376
WHTR 0.549 0.547 0.9801
TG/HDL-C 0.685 0.782 0.1777
HDL-C/TC 0.704 0.818 0.0995
Metabolic Syndrome
BMI 0.527 0.562 0.6725
WC 0.533 0.646 0.1655
WTR 0.563 0.364 0.0142
WHR 0.634 0.642 0.9217
WHTR 0.54 0.61 0.395
TG/HDL-C 0.81 0.782 0.684
HDL-C/TC 0.625 0.764 0.0716
All values were area under the curve (AUC).
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http://www.lipidworld.com/content/11/1/101Ghanaian studies on physical activity or inactivity and its
relation to obesity, evidence of physical inactivity is
obtained from the growing problem of overweight
(12.7%) and obesity (25.3%) especially among non-
pregnant women aged 15–49 years [48]. Visceral fat in
thighs can affect the activity of lipoprotein lipase result-
ing in increase in exposure of muscles to free fatty acids
through uptake and storage. One of the sites responsible
for insulin resistance is muscle mass [46]. The ratios
TG/HDL-C and HDL-C/TC are associated with thigh
circumference and WHR among postmenopausal
women in this study (Table 3). This finding buttresses
the point that the TG/HDL-C and HDL-C/TC can be
explored as diagnostic tool for metabolic syndrome as
well as atherosclerosis. In order to decrease the risk of
metabolic syndrome and atherosclerosis among preme-
nopausal and postmenopausal Ghanaian women, in gen-
eral, life style modification to control weight, lipid
profile, blood pressure and blood glucose should be
emphasized.
Conclusion
The present study suggested that WC, WHR, WHtR,
TG/HDL-C and HDL-C/TC values were all associated
with traditional metabolic risk factors. Waist-to-thigh
ratio associated with raised glucose and triglyceride
values. In Ghanaian postmenopausal women, waist cir-
cumference, WHR, TG/HDL-C and HDL-C/TC pre-
dicted the presence of metabolic syndrome.Abbreviations
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lipoprotein cholesterol-total cholesterol ratio; TG/HDL-C: Triglyceride-high
density lipoprotein cholesterol ratio; CETP: Cholesterol ester transport
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